Litcius/Paper detail

Quantitative inspiratory–expiratory chest CT findings in COVID-19 survivors at the 6-month follow-up

Xi Jia, Xiaoyu Han, Yukun Cao, Yanqing Fan, Mei Yuan, Yumin Li, Jin Gu, Yuting Zheng, Li Wang, Yali Qu, Heshui Shi

2022Scientific Reports27 citationsDOIOpen Access PDF

Abstract

Abstract We evaluated pulmonary sequelae in COVID-19 survivors by quantitative inspiratory–expiratory chest CT (QCT) and explored abnormal pulmonary diffusion risk factors at the 6-month follow-up. This retrospective study enrolled 205 COVID-19 survivors with baseline CT data and QCT scans at 6-month follow-up. Patients without follow-up pulmonary function tests were excluded. All subjects were divided into group 1 (carbon monoxide diffusion capacity [DL CO ] < 80% predicted, n = 88) and group 2 (DL CO ≥ 80% predicted, n = 117). Clinical characteristics and lung radiological changes were recorded. Semiquantitative total CT score (0–25) was calculated by adding five lobes scores (0–5) according to the range of lesion involvement (0: no involvement; 1: < 5%; 2: 5–25%; 3: 26–50%; 4: 51–75%; 5: > 75%). Data was analyzed by two-sample t-test, Spearman test, etc. 29% survivors showed air trapping by follow-up QCT. Semiquantitative CT score and QCT parameter of air trapping in group 1 were significantly greater than group 2 ( p < 0.001). Decreased DL CO was negatively correlated with the follow-up CT score for ground-glass opacity (r = − 0.246, p = 0.003), reticulation (r = − 0.206, p = 0.002), air trapping (r = − 0.220, p = 0.002) and relative lung volume changes (r = − 0.265, p = 0.001). COVID-19 survivors with lung diffusion deficits at 6-month follow-up tended to develop air trapping, possibly due to small-airway impairment.

Topics & Concepts

Air trappingMedicineLung volumesCoronavirus disease 2019 (COVID-19)Pulmonary function testingLungDiffusing capacityNuclear medicineAirwayGround-glass opacityRespiratory systemInternal medicineLung functionAnesthesiaAdenocarcinomaCancerDiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19COVID-19 Clinical Research StudiesChronic Obstructive Pulmonary Disease (COPD) Research